The 15th European LeukemiaNet Symposium will take place from 20-22 March 2018 in Venice, Italy.The HARMONY session is scheduled on 22 March in the morning program.
HARMONY partners will provide an update as well as an AML pilot working meeting. HARMONY Partners involved are:
WP2 Leader, L. Bullinger, Professor in Personalized Medicine, Charité
WP3 Leader: M. van Speybroeck, Director Data Sciences, JPNV-JANSSEN
WP3 Leader: R. Villoria Medina, Project Coordinator, GMV Soluciones Globales Internet
WP4 Leader: R. Hehlmann, Professor of Medicine, ELN Foundation
The European LeukemiaNet (ELN) is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and excellence. ELN is a HARMONY Partner. 220 Participating Centers in 40 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care.
Prof. Rüdiger Hehlmann, Founder and Chair of the European LeukemiaNet (ELN) and founder and Chair of the ELN Foundation published an article in Cancer last year about advancing a field by building consortia.
Receive the latest news. Click here to subscribe!